Development of De Novo Aortic Insufficiency in Patients With HeartMate 3

Volume: 114, Issue: 2, Pages: 450 - 456
Published: Aug 1, 2022
Abstract
De novo aortic insufficiency (AI) is a common adverse event after continuous-flow left ventricular assist device (LVAD) placement and is associated with morbidity and mortality. This study aims to compare the development of de novo AI between HeartMate 3 (Abbott) and HeartMate II LVAD recipients.A retrospective review was conducted of clinical characteristics and serial echocardiograms (1 month, 6 months, and 1 year postimplantation) of...
Paper Details
Title
Development of De Novo Aortic Insufficiency in Patients With HeartMate 3
Published Date
Aug 1, 2022
Volume
114
Issue
2
Pages
450 - 456
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.